Fitch Affirms Investment Grade Rating of ’BBB-’ for Heimstaden Bostad, Raised Outlook to Stable
Reading Time: < 1 minute Fitch affirms Heimstaden Bostad’s Long-Term Issuer Default rating (IDR) of ‘BBB-‘ and raises the Outlook to Stable from Negative. Co-CEO Christian Fladeland comments: “The stable outlook validates that Heimstaden Bostad continues to deliver on its base case performance which
Sobi’s full year 2024 revenue higher than previous estimate
Reading Time: 2 minutes Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO:SOBI) announces today that revenue for the full year 2024 was higher than previous estimate. Full-year revenue was approximately SEK 26,000 M, representing approximately 19% growth at constant exchange rate (CER) (1). Adjusted EBITA margin (1,2)
ABAX disputes Greater Than’s claims in its entirety
Reading Time: < 1 minute Read original Larvik (Norway), January 10, 2025 – In reference to the press release of January 10th issued by Greater Than, accusing ABAX of infringing upon contractually regulated intellectual property (IP) rights, ABAX categorically refutes these allegations. ABAX find it
STENOCARE A/S announces guarantee commitments in ongoing rights issue
Reading Time: 3 minutes STENOCARE A/SNASDAQ FIRST NORTH GROWTH MARKET, DENMARKTICKER: STENO STENOCARE A/S (“Stenocare” or the “Company”) announces that the Company has received a legally binding guarantee commitment of 2 mDKK from Exelity AB, securing approximately 9.9 percent of the total issue corresponding to approximately
2025 Roadmap: Boomerang Partners Targets Growth in iGaming
Reading Time: 2 minutes Boomerang Partners has shared its plans for 2025. This rapidly growing global company is preparing for new products and global expansion. After a successful 2024, it is ready to strengthen its position in iGaming with a key focus on sports betting. Boomerang
Invitation to monthly digital events and presentations of quarterly report
Reading Time: < 1 minute Hamlet BioPharma is pleased to announce the continuation of the digital event series in the spring of 2025. These events provide participants a valuable opportunity to follow and discuss our drug development process and engage directly with our team during
UNION therapeutics to present at the Dermatology Summit 2025, opening the week of the 43rd Annual J.P. Morgan Health Care Conference
Reading Time: 2 minutes Hellerup, Denmark, January 10, 2025 – UNION therapeutics A/S (UNION), a privately held, clinical stage, pharmaceutical development company focused on immunology, today announced that CEO Dr. Kim Kjøller will present at the Dermatology Summit, January 12th 2025 at the Hyatt Regency
NIVEA India Sets a GUINNESS WORLD RECORDS With Largest Online Video Chain of People Passing and Applying Moisturiser
Reading Time: 3 minutes Mumbai, Maharashtra, India: NIVEA, India’s No. 1 trusted skincare brand*, has made history with it’s NIVEA Soft moisturiser by setting a new GUINNESS WORLD RECORDS for the Largest online video chain of people passing and applying moisturiser on 18th December 2024.
SOFTSWISS Game Aggregator Certified for Peru Market
Reading Time: 2 minutes SOFTSWISS has successfully obtained compliance certification for the Peruvian market for its Game Aggregator, the largest content hub in the iGaming sector. This milestone solidifies the company’s position as one of the first technology providers ready to work under the country’s
A Revolutionary Partnership for Indian Creators Between Dhandeel and Ikonic Global
Reading Time: 2 minutes Dhandeel, an AI-driven funding platform for Indian creators, has partnered with UAE-based Ikonic Global to introduce a transformative initiative, Ikonic India, set to launch on January 18, 2025. This groundbreaking collaboration aims to empower Indian creators by providing the resources, funding, and global distribution tools